A detailed history of Gsa Capital Partners LLP transactions in Iradimed Corp stock. As of the latest transaction made, Gsa Capital Partners LLP holds 7,701 shares of IRMD stock, worth $338,381. This represents 0.03% of its overall portfolio holdings.

Number of Shares
7,701
Holding current value
$338,381
% of portfolio
0.03%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$41.17 - $47.29 $317,050 - $364,180
7,701 New
7,701 $338,000
Q3 2019

Nov 12, 2019

SELL
$18.06 - $24.1 $204,096 - $272,354
-11,301 Closed
0 $0
Q2 2019

Aug 06, 2019

SELL
$19.6 - $29.31 $50,862 - $76,059
-2,595 Reduced 18.67%
11,301 $231,000
Q1 2019

May 15, 2019

BUY
$23.58 - $28.43 $49,518 - $59,703
2,100 Added 17.8%
13,896 $390,000
Q4 2018

Feb 12, 2019

BUY
$20.63 - $34.04 $30,945 - $51,060
1,500 Added 14.57%
11,796 $289,000
Q3 2018

Nov 13, 2018

BUY
$20.6 - $37.15 $212,097 - $382,496
10,296 New
10,296 $382,000

Others Institutions Holding IRMD

About IRADIMED CORP


  • Ticker IRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 12,565,100
  • Market Cap $552M
  • Description
  • IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...
More about IRMD
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.